<code id='A946C86303'></code><style id='A946C86303'></style>
    • <acronym id='A946C86303'></acronym>
      <center id='A946C86303'><center id='A946C86303'><tfoot id='A946C86303'></tfoot></center><abbr id='A946C86303'><dir id='A946C86303'><tfoot id='A946C86303'></tfoot><noframes id='A946C86303'>

    • <optgroup id='A946C86303'><strike id='A946C86303'><sup id='A946C86303'></sup></strike><code id='A946C86303'></code></optgroup>
        1. <b id='A946C86303'><label id='A946C86303'><select id='A946C86303'><dt id='A946C86303'><span id='A946C86303'></span></dt></select></label></b><u id='A946C86303'></u>
          <i id='A946C86303'><strike id='A946C86303'><tt id='A946C86303'><pre id='A946C86303'></pre></tt></strike></i>

          00:00
          00:00 00:00 LIVE
          buffering
          Replay
          LIVE
          00:00 / 00:00
          LIVE
          CC
          Opacity :
          Share:
          Close

          entertainment

          author:explore    - browse:79
          A DNA helix, with dollar banknotes covering its strands, collapses next to another DNA helix with dollar banknotes strands — coverage from STAT
          Adobe

          The closely watched gene-editing startup Prime Medicine is embroiled in a multimillion-dollar dispute with another biotech it partnered with to develop a potentially powerful new form of genome editing.

          Prime and Myeloid Therapeutics, a startup co-founded by Pulitzer Prize-winning writer and cancer biologist Siddhartha Mukherjee, have filed competing arbitration claims over a deal they signed in March 2022.

          advertisement

          Prime, spun out of the lab of Broad Institute biochemist David Liu, was built on technology for making small insertions, deletions, and single-letter changes in DNA. In theory, prime editing allows researchers to tackle the vast majority of disease-causing mutations, and the first treatments are already being readied for clinical trials. But it’s a poor fit in cases where hundreds or even thousands of different mutations in a long gene cause the same diseases, such as cystic fibrosis or Duchenne muscular dystrophy.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge